Insurers - What Medicine Is Actually Best?
I often speak to insurance companies who are curious about what medicines are the best value for money for their members.?
It makes sense.?
Patients should be paying for the medicines that will get them the best results, not the best marketed products.?
In healthcare there’s an information asymmetry where the patients and insurers are totally reliant on the doctors to tell them the best course of treatment.?
That makes sense. The doctors are the experts!
However, these doctors are very time constrained, and don’t have the time nor capacity to read the latest research to know what medicine performs the best for each demographic.
The overall result is that doctors are influenced by the latest Medical Sales Rep who has recently seen them.
This is not ideal because we all know the Rep will always find a reason to say why their product is the best.
What if insurers were able to assess and recommend different products to doctors based on what performs best in the real world?
Something that is based on the results of real-world patients not those in nuanced study or report.?
Insurers you are able to do TODAY by using your EXISTING data.
Kapsule is ready to help you to get those answers!?
If you’re an insurer who is interested in identifying which medicine provides your members with the most bang for buck!
Feel free to reach me at [email protected].?
Chief Medical Officer at Penda Health
2 周This is an interesting concept, David. Penda has an enormous patient-reported outcome data set -- almost a quarter million unique outcomes reported by patients after their visits at Penda. However, it's not easy to see clearly which drugs seem to be better in different patient groups. There are so many nuances to this, especially since insured patients tend to prefer original brand drugs. But insured patients have a huge confounder, which is that they tend to be wealthier and have better health and recover faster. So I think we not only need huge data sets, but we need to continue to invest in RCTs in these settings to really know what treatments are more effective and which are marketing ploys.